+1 855 639 5863


Special Populations Life Science

Company Bridging Science, Technology,

And Research to

Create Products For

Effective And Inclusive Outcomes

To truly close the gap of health inequities in therapeutic outcomes, we’re creating and utilizing platforms that propel us to become proactive in our therapeutic quest for science and discovery to treat every patient.


The tech that we’re powered by.

Virtual Clinical Trials

A system in which the patient can participate in clinical research within given approved health conditions from their couch.

Programmatic Therapeutics

Using designed therapies to focus on their overall increased outcomes for better care.


Heuristic Models

Our Areas of Support

With tools at our disposal, we’re supporting and delivering services for life science companies to overcome their challenges.


Advisory and subject matter expertise to support organizational challenges

Data Analytics

We put data endpoints together to enable strategic decision-making


SME’s supporting federal responses nationally and globally


Our therapeutic pipeline to support our growing targeted research areas.

Medical Expertise

Working in regions across the globe, we’ve come to understand specific disease disciplines very well and work hard to support a growing number of organizations on the viability of effective research outcomes.

Infectious Disease

Ultra Rare Disease

Rare Disease

Neglected, Unknown, and Environmental Diseases

Notable Projects






Hemorrhagic Fever

Latest News & Articles

Rubix LS on Pharma Tech Outlook

Rubix LS on Pharma Tech Outlook

Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...

read more
What we’re doing for the COVID-19 crisis…

What we’re doing for the COVID-19 crisis…

In the wake of the current COVID-19 crisis plaguing the world, many life science and health technology organizations are mobilizing ways to assist in containing and managing patient symptoms as well as racing toward a vaccine. While the world is approximately 12-18...

read more